Anika Therapeutics commenced limited market release of the RevoMotion Reverse Shoulder Arthroplasty (RSA) System, with the first surgeries performed in the United States. Full market release is slated for late 2023.
Key benefits of RevoMotion include:
Industry’s smallest diameter threaded glenoid baseplate, which preserves bone and provides flexibility in positioning
Simplified component insertion: the baseplate and glenosphere designs offer unique insertion methods, allowing the surgeon to slide the components on anteriorly with a positive lock
Bone-preserving glenoid and humeral designs intended to provide patient personalization via numerous humeral tray offerings which match the native anatomy
Two streamlined instrument trays
Cheryl R. Blanchard, Ph.D., President and CEO, Anika Therapeutics, said, “With the launch of RevoMotion, surgeons can now address the full spectrum of shoulder arthroplasty repairs, including the fastest growing segment of shoulder arthroplasty, reverse shoulders, with Anika products. RevoMotion marks the second of three key new product launches planned for 2023/2024 and complements the momentum we already have in other recent launches.”
Anika Therapeutics commenced limited market release of the RevoMotion Reverse Shoulder Arthroplasty (RSA) System, with the first surgeries performed in the United States. Full market release is slated for late 2023.
Key benefits of RevoMotion include:
Industry’s smallest diameter threaded glenoid baseplate, which preserves bone and...
Anika Therapeutics commenced limited market release of the RevoMotion Reverse Shoulder Arthroplasty (RSA) System, with the first surgeries performed in the United States. Full market release is slated for late 2023.
Key benefits of RevoMotion include:
Industry’s smallest diameter threaded glenoid baseplate, which preserves bone and provides flexibility in positioning
Simplified component insertion: the baseplate and glenosphere designs offer unique insertion methods, allowing the surgeon to slide the components on anteriorly with a positive lock
Bone-preserving glenoid and humeral designs intended to provide patient personalization via numerous humeral tray offerings which match the native anatomy
Two streamlined instrument trays
Cheryl R. Blanchard, Ph.D., President and CEO, Anika Therapeutics, said, “With the launch of RevoMotion, surgeons can now address the full spectrum of shoulder arthroplasty repairs, including the fastest growing segment of shoulder arthroplasty, reverse shoulders, with Anika products. RevoMotion marks the second of three key new product launches planned for 2023/2024 and complements the momentum we already have in other recent launches.”
Copy to clipboard 
